-
Signature
-
/s/ Kathleen Scott, Attorney-in-Fact
-
Stock symbol
-
SPRY
-
Transactions as of
-
Nov 9, 2022
-
Transactions value $
-
-$653,579
-
Form type
-
4
-
Date filed
-
5/10/2023, 04:53 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SPRY |
Common Stock |
Sale |
-$201K |
-43.9K |
-17.27% |
$4.58 |
210K |
Nov 9, 2022 |
Direct |
F1, F2 |
transaction |
SPRY |
Common Stock |
Options Exercise |
$72.5K |
+57.1K |
+27.15% |
$1.27* |
267K |
May 8, 2023 |
Direct |
|
transaction |
SPRY |
Common Stock |
Sale |
-$352K |
-57.1K |
-21.35% |
$6.16 |
210K |
May 8, 2023 |
Direct |
F3, F4 |
transaction |
SPRY |
Common Stock |
Options Exercise |
$54.5K |
+42.9K |
+20.39% |
$1.27* |
253K |
May 9, 2023 |
Direct |
|
transaction |
SPRY |
Common Stock |
Sale |
-$228K |
-42.9K |
-16.94% |
$5.31 |
210K |
May 9, 2023 |
Direct |
F3, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SPRY |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-57.1K |
-14.17% |
$0.00 |
346K |
May 8, 2023 |
Common Stock |
57.1K |
$1.27 |
Direct |
F6 |
transaction |
SPRY |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-42.9K |
-12.4% |
$0.00 |
303K |
May 9, 2023 |
Common Stock |
42.9K |
$1.27 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: